{
    "title": "SILVR: Guided Diffusion for Molecule Generation. (arXiv:2304.10905v1 [q-bio.BM])",
    "abstract": "Computationally generating novel synthetically accessible compounds with high affinity and low toxicity is a great challenge in drug design. Machine-learning models beyond conventional pharmacophoric methods have shown promise in generating novel small molecule compounds, but require significant tuning for a specific protein target. Here, we introduce a method called selective iterative latent variable refinement (SILVR) for conditioning an existing diffusion-based equivariant generative model without retraining. The model allows the generation of new molecules that fit into a binding site of a protein based on fragment hits. We use the SARS-CoV-2 Main protease fragments from Diamond X-Chem that form part of the COVID Moonshot project as a reference dataset for conditioning the molecule generation. The SILVR rate controls the extent of conditioning and we show that moderate SILVR rates make it possible to generate new molecules of similar shape to the original fragments, meaning that t",
    "link": "http://arxiv.org/abs/2304.10905",
    "context": "Title: SILVR: Guided Diffusion for Molecule Generation. (arXiv:2304.10905v1 [q-bio.BM])\nAbstract: Computationally generating novel synthetically accessible compounds with high affinity and low toxicity is a great challenge in drug design. Machine-learning models beyond conventional pharmacophoric methods have shown promise in generating novel small molecule compounds, but require significant tuning for a specific protein target. Here, we introduce a method called selective iterative latent variable refinement (SILVR) for conditioning an existing diffusion-based equivariant generative model without retraining. The model allows the generation of new molecules that fit into a binding site of a protein based on fragment hits. We use the SARS-CoV-2 Main protease fragments from Diamond X-Chem that form part of the COVID Moonshot project as a reference dataset for conditioning the molecule generation. The SILVR rate controls the extent of conditioning and we show that moderate SILVR rates make it possible to generate new molecules of similar shape to the original fragments, meaning that t",
    "path": "papers/23/04/2304.10905.json",
    "total_tokens": 905,
    "translated_abstract": "在药物设计中，计算生成具有高亲和力和低毒性的新型可合成化合物是一个巨大的挑战。机器学习模型已经显示出在生成新型小分子化合物方面比传统药效团方法有希望，但需要对特定蛋白质靶点进行大量调整。本文介绍了一种称为选择性迭代潜变量细化（SILVR）的方法，用于在无需重新训练的情况下调节现有基于扩散等变生成模型。该模型允许基于碎片命中情况在蛋白质的结合位点生成适合的新分子。我们使用来自Diamond X-Chem的SARS-CoV-2主蛋白酶片段作为参考数据集，用于调节分子生成。SILVR速率控制了调节程度，我们证明了适度的SILVR速率可以生成与原始片段形状相似的新分子，即具有相似的生物活性药物分子。",
    "tldr": "SILVR是一种基于扩散模型的分子生成方法，无需重新训练模型即可结合具有生物酶作用的蛋白质的结合位点，并能以参考数据集为条件生成符合要求的新分子。",
    "en_tdlr": "SILVR is a molecule generation method based on diffusion model, which can conditionally generate new molecules that fit into a binding site of a protein without retraining the model, based on a reference dataset and fragment hits. It has the potential to generate novel small molecule compounds with high affinity and low toxicity, which is a great challenge in drug design."
}